FDA Inspection 878683 — New York Presbyterian Hospital Weill Cornell Medical College

New York Presbyterian Hospital Weill Cornell Medical College — FEI 3003972369

The FDA completed an inspection of New York Presbyterian Hospital Weill Cornell Medical College on May 14, 2014 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 14, 2014
Fiscal Year
2014
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
New York, NY (United States)